SAN CLEMENTE, Calif., July 27, 2017 -- CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its second quarter 2017 financial results after the market closes on Wednesday, August 2, 2017. Representatives of CareTrust REIT's management team will host a conference call to discuss the results the following day.
Conference Call
CareTrust REIT invites current and prospective investors to tune in to its call on Thursday, August 3, 2017 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time), during which CareTrust REIT's management team will discuss the company's second quarter 2017 performance and other current matters. The dial-in number for this call is (844) 220-4972 (U.S.) or (317) 973-4053 (International). The conference ID number is 61282740.
To listen to the call online as a webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the CareTrust REIT website at http://investor.caretrustreit.com/. The call will be recorded, and will be available for replay via the website for 30 days following the call.
About CareTrust REITTM
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 164 net-leased healthcare properties and three operated seniors housing properties in 23 states, CareTrust REIT is pursuing opportunities nationwide to acquire additional properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses. More information about CareTrust REIT is available at www.caretrustreit.com.
Contact: CareTrust REIT, Inc. (949) 542-3130 [email protected]


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Approves Mitapivat for Anemia in Thalassemia Patients
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 



